WIN-R Study Demonstrates Efficacy of Shorter PEG-INTRON and REBETOL Regimen in Hepatitis C Patients with Genotype 2 or 3

Columbia University Medical Center provides international leadership in pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders in health care and includes the dedicated work of many physicians, scientists, nurses, dentists, and public health professionals at the College of Physicians & Surgeons, the School of Dental & Oral Surgery, the School of Nursing, the Mailman School of Public Health, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. http://www.cumc.columbia.edu/newsroom

    
    References
    1. Brown Jr. RS, Jacobson IM, Afdahl N, Freilich B, Pauly MP, Regenstein
       F, Flamm S, Kwo P, Griffel LH, Brass CA, the WIN-R Study Group.
       Differences in treatment outcome to antiviral therapy based on
       genotype and viral load in hepatitis C genotypes 2 and 3 in the WIN-R
       trial. Oral presentation 41 at: 41st Annual Meeting of the European
       Association for the Study of the Liver, Vienna, Austria, April 26-30,
       2006.
    2. SVR is defined as undetectable virus (HCV RNA) levels 24 weeks after
       the end of treatment.
    3. Ince N, Wands JR. The increasing incidence of hepatocellular
       carcinoma. N Engl J Med 1999 March 11;340:10.
    4. Centers for Disease Control and Prevention. Recommendations for
       prevention and treatment of hepatitis C virus (HCV) and HCV-related
       chronic disease. MMWR Weekly Report 1998 Oct. 16;1.
    Contacts:
    Andrea Ziltzer
    Biosector 2
    +1-212-229-8433
    aziltzer@biosector2.com
    Tracy Hickenbottom
    NewYork-Presbyterian Hospital/Columbia
    +1-212-305-5587
    trh9001@nyp.org
    Craig Lemoult
    Columbia University Medical Center
    +1-212-305-0820
    cel2113@columbia.edu
    Web site: http://www.nyp.org
              http://www.cumc.columbia.edu/newsroom

Andrea Ziltzer of Biosector 2, +1-212-229-8433, aziltzer@biosector2.com; or Tracy Hickenbottom of NewYork-Presbyterian Hospital-Columbia, +1-212-305-5587, trh9001@nyp.org; or Craig Lemoult of Columbia University Medical Center, +1-212-305-0820, cel2113@columbia.edu